Introduction to Nanoscience and Nanotechnology. Chris Binns

Чтение книги онлайн.

СКАЧАТЬ as 300 nm and allows gas molecules to diffuse across.

      Source: Patrick J. Lynch https://commons.wikimedia.org/wiki/File:Bronchial_anatomy.jpg. Licensed under CC BY 2.5.

      (b) Alveolar macrophages, typically 10 μm across that occupy the lungs and the alveoli. They ingest particles by phagocytosis and are carried up through the lung system by a slow mucus flow called the mucociliary escalator. They are eventually swallowed and pass out through the digestive system.

      Source: Reproduced with permission from [4].

      Since humans have evolved in the presence of atmospheric aerosols, the body has well‐developed mechanisms to cope with inhaled particles including nanoparticles. Dispersed throughout the airways of the lung right down to the alveoli are specialized cells with typical sizes of around 10 μm known as macrophages (Figure 2.4b). These are able to ingest particles using a mechanism (phagocytosis) in which the cell wall of the macrophage envelops the foreign body and passes it through to the interior. The cells are passed, with their cargo of absorbed particles, to the top of the lungs by a gradual upward drift of mucus, called the mucociliary escalator, so they can be swallowed and passed out through the digestive system. It typically takes the escalator about 70 days to clear a particle from the deepest part of the lungs through this time increase if the number of particles starts to overwhelm the macrophages. Particles deposited near the top of the airway can also adhere directly to the mucus and be removed by the mucociliary escalator.

The system copes admirably with the huge number of particles that we constantly breathe in, which can be estimated to be about 15 million per breath and, according to Figure 2.2, made up almost exclusively of nanoparticles with diameters smaller than 100 nm. There are, however, several fundamental mechanisms by which over‐exposure to nanoparticles can adversely affect health, the first one being their tendency to overwhelm the clearance process. It has been known for some time that phagocytosis works best for particles with sizes around 1 μm but becomes inefficient for particle sizes below 100 nm [5]. More recent studies have shown that the clearance time for nanoparticles of titanium dioxide with a diameter of 20 nm is significantly longer than particles with a diameter of 200 nm [6]. In addition, titanium dioxide in the form of nanoparticles results in a greater incidence of tumors than larger particles. Other studies have shown that preexposure of macrophages to titanium dioxide or carbon nanoparticles limits their ability to subsequently ingest larger particles by phagocytosis [7]. Thus, nanoparticles are cleared slowly but in addition, they can slow down the clearance of all particles, including those that are micron‐sized, so their over‐abundance can lead to chronic exposure and increased risk of tumors forming.

      Inhaled nanoparticles can also affect parts of the body away from the lungs and cardiovascular disease is one well‐known consequence of their inhalation [8]. One hypothesis for the cause is that the particles produce inflammation within the lungs that results in the systemic release of cytokines. These are small proteins involved in cell signaling and regulation of the immune system and their release can have adverse side effects on the cardiovascular system. Another important mechanism that allows nanoparticles, especially those near the bottom end of the size scale (5–10 nm), to have a systemic effect is that they are able to translocate. That is, they pass through the alveoli into the blood circulation and are then deposited around the body.

Recently, the first systematic study of the translocation of nanoparticles in humans [9] was carried out using gold (Au) nanoparticles produced in an aerosol by a spark source (see Chapter 5, Section 5.1.6). During moderate exercise, fourteen male volunteers breathed in the aerosol consisting of 18.7 nm diameter Au nanoparticles at a density of 6 × 10⁶/cm³. This is about 10 times the number density of all nanoparticles of the same size in the ambient background (see Figure 2.2). Blood and urine samples were taken over the first 24 hours and then again after three months and the amount of Au in the samples was measured using mass spectrometry. The results for the 18.7 nm diameter nanoparticles are shown in Figure 2.5a and it is evident that the nanoparticles are detectable in the blood almost immediately in some patients. After six hours Au was present in the blood samples of most (12/14) of the volunteers and was still detectable in half the patients after three months. This indicates that the nanoparticles stay in the lungs for a considerable time, which is consistent with their slow removal, as described above, and they are slowly absorbed over a long time. It should be emphasized that a rough estimate of the proportion of Au nanoparticles of this size that are translocated is 0.02% but the study clearly showed that translocation is a viable mechanism for breathed in nanoparticles to have a systemic effect.

The same study also examined the effect of particle size on translocation with the results shown in Figure 2.5b. It is evident that a much lower fraction of larger particles is able to enter the bloodstream as would be expected. Not all the particles were passed out into the urine or feces and animal studies showed the accumulation of Au nanoparticles in tissues especially at sites of lesions, which could be a mechanism for triggering cardiovascular disease.

Figure 2.5 Translocation of Au nanoparticles from the lungs into blood circulation. (a) Percentage of 14 volunteers with detectable Au in the blood as a function of time after breathing in a Au aerosol of 18.7 nm diameter Au nanoparticles. (b) Effect of nanoparticle size on translocation as a function of time in 10 volunteers (small particles) and nine volunteers (large particles).

      Source: Reproduced with the permission of the American Chemical Society from M. R. Miller et al. [9].

Figure 2.6 Frustrated phagocytosis. Scanning electron microscopy image of macrophages undergoing frustrated phagocytosis induced by (a) multiwalled carbon nanotubes and (b) an asbestos fiber.

      Source: Reproduced from [10].

Fibrous nanomaterials in the form of carbon nanotubes (see Chapter 3) introduce an additional hazard that has been known for some time in the case of glass and asbestos fibers. Since the macrophages have a typical size of 10–15 μm, fibers longer than this lead to a phenomenon known as frustrated phagocytosis when the macrophage attempts to ingest the fiber. The foreign object is not fully encased leading to a release of digestive enzymes, toxic oxygen, and nitrogen, which can damage nearby healthy cells. Figure 2.6b shows an electron microscope image of frustrated phagocytosis after a macrophage has tried to ingest an asbestos fiber and Figure 2.6a shows a group of macrophages undergoing frustrated phagocytosis of carbon nanotubes.

      2.2.2 Entry Via the Intestines

The lung clearance mechanism is designed to get the nanoparticles out of the lung and into the digestive system via the saliva and removed from the body by the reticuloendothelial system (RES) described in Chapter 8, Section 8.1.2. The system removes the vast majority of nanoparticles via СКАЧАТЬ